Targeting vascular (endothelial) dysfunction

A Daiber, S Steven, A Weber… - British journal of …, 2017 - Wiley Online Library
Cardiovascular diseases are major contributors to global deaths and disability‐adjusted life
years, with hypertension a significant risk factor for all causes of death. The endothelium that …

Redox control of endothelial function and dysfunction: molecular mechanisms and therapeutic opportunities

SR Thomas, PK Witting… - Antioxidants & redox …, 2008 - liebertpub.com
The endothelium is essential for the maintenance of vascular homeostasis. Central to this
role is the production of endothelium-derived nitric oxide (EDNO), synthesized by the …

Nitrosative stress and its association with cardiometabolic disorders

I Pérez-Torres, L Manzano-Pech, ME Rubio-Ruíz… - Molecules, 2020 - mdpi.com
Reactive nitrogen species (RNS) are formed when there is an abnormal increase in the level
of nitric oxide (NO) produced by the inducible nitric oxide synthase (iNOS) and/or by the …

Novel pharmacological approaches to the treatment of renal ischemia-reperfusion injury: a comprehensive review

PK Chatterjee - Naunyn-Schmiedeberg's archives of pharmacology, 2007 - Springer
Renal ischemia-reperfusion (IR) contributes to the development of ischemic acute renal
failure (ARF). Multi-factorial processes are involved in the development and progression of …

Targeting parthanatos in ischemic stroke

RC Koehler, VL Dawson, TM Dawson - Frontiers in neurology, 2021 - frontiersin.org
Parthanatos is a cell death signaling pathway in which excessive oxidative damage to DNA
leads to over-activation of poly (ADP-ribose) polymerase (PARP). PARP then generates the …

Role of nitrosative stress in the pathogenesis of diabetic vascular dysfunction

C Szabo - British journal of pharmacology, 2009 - Wiley Online Library
Here we overview the role of reactive nitrogen species (nitrosative stress) and associated
pathways in the pathogenesis of diabetic vascular complications. Increased extracellular …

PARP-1: a critical regulator in radioprotection and radiotherapy-mechanisms, challenges, and therapeutic opportunities

WH Li, F Wang, GY Song, QH Yu, RP Du… - Frontiers in …, 2023 - frontiersin.org
Background: Since its discovery, poly (ADP-ribose) polymerase 1 (PARP-1) has been
extensively studied due to its regulatory role in numerous biologically crucial pathways …

Poly (ADP‐ribose) polymerase 1 (PARP1) in atherosclerosis: from molecular mechanisms to therapeutic implications

S Xu, P Bai, PJ Little, P Liu - Medicinal research reviews, 2014 - Wiley Online Library
Poly (ADP‐ribosyl) ation reactions, carried out by poly (ADP‐ribose) polymerases
(PARPs/ARTDs), are reversible posttranslational modifications impacting on numerous …

DNA damage and repair in atherosclerosis: current insights and future perspectives

T Cervelli, A Borghini, A Galli… - International journal of …, 2012 - mdpi.com
Atherosclerosis is the leading cause of morbidity and mortality among Western populations.
Over the past two decades, considerable evidence has supported a crucial role for DNA …

The role of DNA damage and repair in atherosclerosis: A review

NR Shah, M Mahmoudi - Journal of molecular and cellular cardiology, 2015 - Elsevier
The global burden of cardiovascular disease is increasing despite therapeutic advances in
medication and interventional technologies. Accumulated deoxyribonucleic acid (DNA) …